Skip to main content

Adia Nutrition, Inc.

corporate_fare Company Profile

Adia Nutrition, Inc.

ADIA·OTC·Life Sciences·CIK 0001160420

Adia Nutrition, Inc. provides medical treatments and nutritional supplements. The company operates through three segments: Biolete, Adia Med, and Adia Labs. Its Biolete segment offers autologous hematopoietic stem cell transplantation (AHSCT) treatments specifically for patients with multiple sclerosis. The Adia Med segment functions as a clinic where these stem cell treatments are performed. The Adia Labs segment is responsible for procuring and selling stem cell products, both to external clinics and to Adia Med. In addition to these medical services, Adia Nutrition, Inc. also offers a range of nutritional supplements and biologic products. The company distributes its products directly to consumers and through other direct-to-consumer channels. Adia Nutrition, Inc. was previously known as PivX Solutions Inc. and adopted its current name in May 2004. The company's headquarters are located in Winter Park, Florida.

Adia Nutrition, Inc. (OTC:ADIA) is a publicly traded company in the Life Sciences sector. Wiseek monitors ADIA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Adia Nutrition Secures Expanded Stem Cell Coverage for 250,000+ Members Through Health Care Sharing Ministry
  • Adia Nutrition Reports Worsening Losses, Going Concern Warning, and Ineffective Controls; Omits Recent Positive News
  • Adia Nutrition's Groundbreaking Kidney Disease Stem Cell Study Receives IRB Approval, Nears Patient Enrollment
  • Adia Nutrition Partners for 100-Patient Autism Study, Supplying 300 High-Value Regenerative Infusions
  • Adia Nutrition Faces Going Concern Doubt, Ineffective Controls, and Lacks Insider Trading Policies in Annual Report

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$700.51K
Net Income
-$395.46K
Diluted EPS
$0.00
Op. Cash Flow
-$179.23K
Free Cash Flow
-$192.43K
Gross Profit
$191.67K
Operating Income
-$366.49K
Cash & Equivalents
$79.39K
Debt / Equity
0.00×
Net Margin
-56.5%
Shares Outstanding
93.6M sh
Source: 10-K · filed 2026-03-31 · accession 0001683168-26-002531
Browse all tickers starting with A →
$0.16
52-week range · as of 2026-05-15 $0.0177 – $0.2777
Market cap
$15.1M
Volume
1.4K (0.1× avg)
3-mo avg 13.8K
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ADIA - Latest Insights

ADIA
May 26, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Adia Nutrition Secures Expanded Stem Cell Coverage for 250,000+ Members Through Health Care Sharing Ministry
Price at Filing: $0.160
Real-time Price: $0.160 info
Change: $0 (0%) info
Market Cap: $15.105M info
Sentiment: Positive
View Wiseek Article
ADIA
May 14, 2026, 9:32 PM EDT
Filing Type: 10-Q
Importance Score:
9
Adia Nutrition Reports Worsening Losses, Going Concern Warning, and Ineffective Controls; Omits Recent Positive News
Price at Filing: $0.170
Real-time Price: $0.160 info
Change: -$0.010 (-6%) info
Market Cap: $15.105M info
Sentiment: Negative
View Wiseek Article
ADIA
May 05, 2026, 10:08 AM EDT
Source: TMX Newsfile
Importance Score:
8
Adia Nutrition's Groundbreaking Kidney Disease Stem Cell Study Receives IRB Approval, Nears Patient Enrollment
Price at Filing: $0.150
Real-time Price: $0.160 info
Change: +$0.010 (+7%) info
Market Cap: $15.105M info
Sentiment: Positive
View Wiseek Article
ADIA
Apr 08, 2026, 8:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Adia Nutrition Partners for 100-Patient Autism Study, Supplying 300 High-Value Regenerative Infusions
Price at Filing: $0.113
Real-time Price: $0.160 info
Change: +$0.047 (+42%) info
Market Cap: $15.105M info
Sentiment: Positive
View Wiseek Article
ADIA
Mar 31, 2026, 3:49 PM EDT
Filing Type: 10-K
Importance Score:
9
Adia Nutrition Faces Going Concern Doubt, Ineffective Controls, and Lacks Insider Trading Policies in Annual Report
Price at Filing: $0.100
Real-time Price: $0.160 info
Change: +$0.060 (+60%) info
Market Cap: $15.105M info
Sentiment: Negative
View Wiseek Article